Bevacizumab (Avastin) is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGFA). VEGF-A stimulates angiogenesis in a variety of diseases, including cancer. Bevacizumab was the firs
* VAT and and shipping costs not included. Errors and price changes excepted